FTC Alleges Trump Administration Probe Could Upend Transgender Youth Treatment Guidelines

The Federal Trade Commission alleges that WPATH constructed widely used transgender treatment guidelines for minors based on evidence its own leaders privately acknowledged was limited and uncertain. A potential probe by the Trump administration could dismantle these guidelines, shifting medical standards away from practices lacking robust scientific backing. This move represents a significant shift in the cultural debate over gender identity treatment, prioritizing evidence-based medicine over ideological mandates.